Oncology workshop 1 (colorectal cancer) Flashcards

1
Q

Why is staging in cancer important?

A
  • Prognosis
  • Treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why does staging change over time?

A
  • Due to better treatment and investigations and technology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain staging in colorectal cancer (Dukes’ criteria)

A
  • Dukes’ A Cancer has grown into the inner layer or muscle layer of the bowel wall Not spread to lymph nodes or other parts of the body
  • Dukes’ B Cancer has grown through the muscle layer or outer layer May be growing into tissues near the bowel Not spread to the lymph nodes or other parts of the body
  • Dukes’ C Cancer is any size and has spread to nearby lymph nodes Not spread to other parts of the body
  • Dukes’ D Cancer is any size May or may not have spread to nearby lymph nodes Has spread to other parts of the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain TNM staging

A

American Joint Committee on Cancer

  • TX – Primary tumour cannot be assessed
  • T0 – No evidence of primary tumour
  • Tis – Carcinoma in situ: intraepithelial or invasion of lamina propria
  • T1 – Invades submucosa
  • T2 – Invades muscularis propria
  • T3 – Invades through muscularis propria into subserosa or into non-peritonealised pericolic or perirectal tissues
  • T4 – Directly invades other organs or structures and/or perforates visceral peritoneum
  • NX – Regional lymph nodes cannot be assessed
  • N0 – No regional lymph node metastasis
  • N1 – Metastasis in 1–3 regional lymph nodes
  • N2 – Metastasis in 4 or more regional lymph nodes
  • MX – Distant metastasis cannot be assessed
  • M0 – No distant metastasis
  • M1 – Distant metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Draw T staging

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain grading in (colorectal) cancer

A

What does it look like under the microscope?

  • Grade 1 (low grade)
    • Cancer cells look similar to normal cells (well differentiated)
  • Grade 2 (moderate grade)
    • Cancer cells look more abnormal (moderately differentiated)
  • Grade 3 (high grade)
    • Cancer cells look very abnormal (poorly differentiated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Draw the structure anatomy of the bowel

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the pathology in colorectal cancer

A

What is the most common pathology in colorectal cancer?

  • Adenocarcinoma
  • Well or moderately differentiated

Other pathologies?

  • Mucinous carcinomas
  • Colloid carcinomas

What else do we get in pathology report?

  • Vascular or lymphatic invasion
  • R0, R1, R2 (
  • T N M (more than 12 nodes to accurately stage)
  • Mutations (BRAF, KRAS, NRAS)
  • MSI or MMR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is MMR and MSI?

A
  • Mismatch repair proteins (MMR)
  • MLH1, MSH2, MSH6 or PMS2
  • They keep your microsatellite (MSI) regions of your DNA stable
  • Help prevent carcinogenic mutations
  • If you are MMR proficient you are MSI-stable
  • If you are MMR deficient you are MSI-instable
  • If you are MMR proficient you are MSI-low
  • If you are MMR deficient you are MSI-high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Lynch Syndrome?

A
  • Hereditary non-polyposis colorectal cancer (HNPCC)
  • Most common cause of hereditary colorectal cancer
  • MSH2 and/or MSH6 loss suspicious for Lynch Syndrome
  • Increased risk of lots of cancers
  • Younger age (before 50)
    • Uterine (endometrial)
    • Stomach
    • Liver
    • Kidney
    • Brain
  • Surveillance? (as genetic history = family history)
    • 2 yearly colonoscopies, annual endometrial US +-biopsy, 1-2 yearly OGDs (if +ve family history) → NOT NEED TO KNOW THIS BIT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What factors influence surgical treatment?

A

What factors influence surgical treatment?

  • Location and spread of cancer (nodes and other organs)
  • Blood supply
  • Lymphatic drainage
  • Patient fitness
  • Patient choice!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Draw the blood supply to the bowel

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Draw right hemicolectomy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Draw transverse colectomy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Draw an extended right hemicolectomy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Draw a left hemicolectomy

A
17
Q

Draw a sigmoid colectomy

A
18
Q

What to do with someone with metastatic disease (not for sugery) and presents with bowel obstruction?

A
  • Colectomy
  • Defunctioning stoma
  • Colonic stenting
19
Q

What is the 5 year survival rates after surgical resection alone in different stages? (in CRC)

A
  • 99% for stage I
  • 68%-83% for stage II
  • 45%-65% for stage III
20
Q

If Adjuvant Chemotherapy Stage 2 and MSI-instable/MSI-high/dMMR, treat or not?

A

NO adjuvant chemotherapy

21
Q

Treatment for adjuvant chemotherapy stage 2

A
  • What is stage 2?
    • T3/4 N0 M0
  • 6 months of oral capecitabine (twice a day)
    • Reduces the risk of recurrence by ~5%
  • Get chemotherapy after 12 weeks (not a day over this) of curative surgery
22
Q

Treatment of adjuvant stage 3 cancer

A
  • What is a stage 3?
    • Any T, N1/2, M0
  • Adjuvant benefit to single agent 5-FU was 10%
    • Improved with adding oxaliplatin by 3-5%
    • Now we offer doublet chemo with a 15% benefit
    • Aim to start within 8 weeks of surgery
    • Definitely before 12 weeks